192 related articles for article (PubMed ID: 32665236)
1. Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism.
Filippova OT; Kim SW; Cowan RA; Chi AJ; Iasonos A; Zhou QC; Broach V; Zivanovic O; Long Roche K; Sonoda Y; Gardner G; Chi DS
Int J Gynecol Cancer; 2020 Aug; 30(8):1183-1188. PubMed ID: 32665236
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of post-operative platelet-to-white blood cell ratio after splenectomy in patients with advanced ovarian cancer.
Lathouras K; Panagakis G; Bowden SJ; Saliaris K; Saso S; Haidopoulos D; Fotopoulou C
Int J Gynecol Cancer; 2019 Oct; 29(8):1292-1297. PubMed ID: 31481452
[TBL] [Abstract][Full Text] [Related]
3. Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer.
Bizzarri N; Korompelis P; Ghirardi V; O'Donnell RL; Rundle S; Naik R
Int J Gynecol Cancer; 2020 Jul; 30(7):1043-1051. PubMed ID: 32546641
[TBL] [Abstract][Full Text] [Related]
4. Acute and Chronic Hematologic Implications of Emergency and Elective Splenectomy.
Singer KE; Bercz AP; Morris MC; Elson NC; Wallen TE; Hanseman D; Pritts TA; Nomellini V; Patel SH; Makley AT; Goodman MD
J Surg Res; 2021 Nov; 267():197-202. PubMed ID: 34153562
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytosis in splenic trauma: In-hospital course and association with venous thromboembolism.
Chia TL; Chesney TR; Isa D; Mnatzakanian G; Colak E; Belmont C; Hirpara D; Veigas PV; Acuna SA; Rizoli S; Rezende-Neto J
Injury; 2017 Jan; 48(1):142-147. PubMed ID: 27451291
[TBL] [Abstract][Full Text] [Related]
6. Hematologic changes after splenectomy for cytoreduction: implications for predicting infection and effects on chemotherapy.
Bidus MA; Krivak TC; Howard R; Rose GS; Cosin J; Dainty L; Elkas JC
Int J Gynecol Cancer; 2006; 16(6):1957-62. PubMed ID: 17177832
[TBL] [Abstract][Full Text] [Related]
7. Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country.
Zvizdic Z; Kovacevic A; Milisic E; Jonuzi A; Vranic S
PLoS One; 2020; 15(8):e0237016. PubMed ID: 32756575
[TBL] [Abstract][Full Text] [Related]
8. [Splenectomy as a part of debulking surgery in patients with advanced ovarian cancer].
Derlatka P; Grabowska-Derlatka L; Sieńko J; Dańska-Bidzińska A
Ginekol Pol; 2014 Aug; 85(8):605-8. PubMed ID: 25219141
[TBL] [Abstract][Full Text] [Related]
9. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
[TBL] [Abstract][Full Text] [Related]
10. Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: A review of outcomes.
Rush SK; Lees BF; Huang DS; Peterson MF; Al-Niaimi A
Gynecol Oncol; 2022 Nov; 167(2):283-288. PubMed ID: 36114028
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique.
Macciò A; Sanna E; Lavra F; Chiappe G; Petrillo M; Madeddu C
BMC Surg; 2021 Oct; 21(1):380. PubMed ID: 34711237
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
Chen Y; Zhang L; Liu WX; Liu XY
Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
Pant A; Liu D; Schink J; Lurain J
Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
[TBL] [Abstract][Full Text] [Related]
16. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism.
Visudhiphan S; Ketsa-Ard K; Piankijagum A; Tumliang S
Biomed Pharmacother; 1985; 39(6):264-71. PubMed ID: 4084660
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy is associated with a higher risk for venous thromboembolism: A prospective cohort study.
Lee DH; Barmparas G; Fierro N; Sun BJ; Ashrafian S; Li T; Ley EJ
Int J Surg; 2015 Dec; 24(Pt A):27-32. PubMed ID: 26493210
[TBL] [Abstract][Full Text] [Related]
19. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of thrombocytosis in ovarian cancer.
Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
